Kenia comienza a administrar un nuevo tratamiento inyectable para prevenir el VIH

La semana pasada, Kenia recibió su primer lote de 21.000 dosis gracias a un acuerdo entre el fabricante del lenacapavir, Gilead Sciences, y el Fondo Mundial de lucha contra el sida.


1 w.
Science
ID: -6077390744002729323


Similar News expand_more


Science
Science
Science
Science
Crime
Science
Technology
Science
Technology
Science
Science
Travel
Science
Science
Science
Science
Technology
Science
Crime
Science
Technology
Science
Science
Science
Technology
Politics
Culture
Science
Politics
Politics
Science
Science
Sport
Sport
Technology
Science
Politics
Education
Technology
Science
Politics
Technology
Politics
Culture
Crime
Technology
Politics
Crime
Politics
Popular

Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down